000 | 01765nam a2200373 i 4500 | ||
---|---|---|---|
001 | 2133323 | ||
003 | StDuBDS | ||
005 | 20240729133141.0 | ||
006 | m|||||o||d|||||||| | ||
007 | cr ||||||||||| | ||
008 | 171117s2017 enka fob 001|0|eng|d | ||
020 |
_a9781910797716 (PDF ebook) : _cNo price |
||
020 |
_z9781910797709 (pbk.) : _cNo price |
||
020 | _z9781910797716 | ||
040 |
_aStDuBDS _beng _cStDuBDS _erda _epn |
||
060 | 4 | _aQW 601 | |
100 | 1 |
_aClarke, Stephen _c(Professor of medicine), _eauthor. |
|
245 | 1 | 0 |
_aImmuno-oncology / _h[E-Book] |
264 | 1 |
_aAbingdon, Oxford : _bHealth Press, _c2017. |
|
300 |
_a1 online resource (88 pages) : _billustrations (colour). |
||
490 | 1 | _aFast facts | |
500 | _aAlso issued in print: 2017. | ||
504 | _aIncludes bibliographical references and index. | ||
520 | 8 | _aThe treatment of cancer is being revolutionised by drugs that modulate the immune system, offering the prospect of long-term response and extended survival for many patients with advanced incurable cancer. A plethora of new drugs are being incorporated into current standards of care but many questions remain unanswered - and new ones emerge - about how to use these exciting new drugs to best effect. A good understanding of immune-oncology is therefore becoming increasingly important to keep up to date with this rapidly changing field. | |
521 | _aSpecialized. | ||
588 | _aDescription based on online resource; title from PDF title page (viewed on January 17, 2023). | ||
650 | 0 |
_aImmunotherapy. _96577 |
|
650 | 0 |
_aTumors _xTreatment. |
|
650 | 2 |
_aImmunotherapy. _96577 |
|
650 | 2 |
_aNeoplasms _xtherapy. |
|
700 | 1 |
_aLi, Bob T., _eauthor. |
|
830 | 0 | _aFast facts. | |
856 |
_u#gotoholdings _yAccess resource |
||
999 |
_c96841 _d96841 |